Tag Archives: PTAB

Ex Parte Nagy – The Reach of the Mayo/Alice Rule Exceeds Its Grasp?

The final rejection of the claims of Nagy’s application Serial No. 14/223,113 was affirmed by the PTAB on July 30, 2018 (Appeal 2017-008793). One of the “representative” claims was directed to the holy grail of diagnostics – the early diagnosis … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , , , | Leave a comment

Ex Parte Young – Expanding the Scope of an “Abstract Idea.”

On July 18th, in appeal no. 2017-007443, the PTAB reversed the Examiner’s rejection to an improved method of manipulating the huge amount of DNA sequence information or “text strings” that are provided by applying the techniques of massively parallel sequencing … Continue reading

Posted in PTAB | Tagged , , , , , , , | Leave a comment

Ex Parte Galloway – Berkheimer Meet s. 103 Part II

In Ex parte Galloway, Appeal No. 2017-004696 (PTAB, May 24, 2018), the Board reversed the examiner’s rejections of claims to a method of diagnosing bladder cancer. The method comprised isolating cells from the urine of a subject, dispersing at least … Continue reading

Posted in PTAB, Section 103 | Tagged , , , | Leave a comment

Ex Parte Smith: What We’ve Got Here Is A Failure To Communicate!

In Ex parte Smith, Appeal No. 2016-007565 (PTAB, May 16, 2016), the Board reversed the examiner’s s.101 and 103 rejections of a claim to a modified flavivirus envelop (E) protein comprising a mutated envelop protein, where the unmodified E-To domain … Continue reading

Posted in Section 101 | Tagged , , , , | Leave a comment